Douglas Baum

Direttore/Membro del Consiglio presso Regent GLSC Technologies, Inc.

Patrimonio netto: 5 534 $ in data 30/04/2024

57 anni

20 relazioni

Health Technology

Commercial Services

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
David Arthur Nelson	M	76	Regent GLSC Technologies, Inc. Regent GLSC Technologies, Inc. Medical SpecialtiesHealth Technology Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007.	17 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Christopher Nelson	M	54	QSAM BIOSCIENCES, INC.	20 anni
Steven Pieper	M	47	Xeris Pharmaceuticals, Inc. Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.	-
Kevin M. Bolin	M	60	QSAM BIOSCIENCES, INC.	4 anni
Namrata Chand	F	43	QSAM BIOSCIENCES, INC.	-
Paul Edick	M	67	Xeris Pharmaceuticals, Inc. Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.	-
Adriann Sax	F	63	QSAM BIOSCIENCES, INC.	2 anni
Adam King	M	39	QSAM BIOSCIENCES, INC.	3 anni
Scott W. Whitney	M	67	QSAM BIOSCIENCES, INC.	5 anni
Tristan Anthony Peitz	M	40	QSAM BIOSCIENCES, INC.	3 anni
Jeffrey Soinski	M	61	QSAM BIOSCIENCES, INC.	-
C. Piazza	M	77	QSAM BIOSCIENCES, INC.	20 anni
Joel D. Mayersohn	M	66	QSAM BIOSCIENCES, INC.	8 anni
Jonathan Rigby	M	56	Xeris Pharmaceuticals, Inc. Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.	3 anni
Charles Link	M	64	QSAM BIOSCIENCES, INC.	3 anni
Michelle Murcia	F	56	QSAM BIOSCIENCES, INC.	3 anni
Arthur W. Batson	M	64	QSAM BIOSCIENCES, INC.	-
David Shields	M	-	QSAM BIOSCIENCES, INC.	-
Sudheer M. Pimputkar	M	74	QSAM BIOSCIENCES, INC.	1 anni
Christopher J. Spencer	M	55	QSAM BIOSCIENCES, INC.	2 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	20	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni